Tristan Snell
A
BREAKING -- the DEA is reclassifying cannabis from a Schedule I to a Schedule III drug

Major move from the Biden Administration that will allow cannabis companies to have easier access to banking, investment, and tax credits -- and it opens the door to more medical research
05:27 PM - Apr 30, 2024
Avatar Avatar Avatar
0
6
154
loading...
{{ notificationModalContent }} {{ promptModalMessage }}